Skip to main content
Equibles

MILLENNIUM MANAGEMENT LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1273087 NEW YORK, NY
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$110,629,075
+$53,586,464 QoQ
Shares Held
3,265,321
+72.4% QoQ
Ownership
0.280%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#37
of 675 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Jun 30, 2026
CallValue
$23,282,336
CallShares
687,200
PutValue
$897,820
PutShares
26,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $1,140,219,030 across 49 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (9.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 409,074 $221,648,565
2 SUPN
Supernus Pharmaceuticals, Inc.
 3,853,212 $179,212,890
3 ZTS
Zoetis Inc.
 1,813,759 $130,336,721
4 TEVA
Teva Pharmaceutical Industries Ltd
This page 		3,265,321 $110,629,075
5 INDV
Indivior Pharmaceuticals, Inc.
 2,098,945 $86,119,713
6 ELAN
Elanco Animal Health Inc
 2,725,889 $67,084,128
7 ANIP
Ani Pharmaceuticals Inc
 507,207 $41,986,595
8 LNTH
Lantheus Holdings, Inc.
 336,399 $37,320,105

All Filings in TEVA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $897,820 26,500
2026-06-30 $110,629,075 3,265,321
2026-06-30 $23,282,336 687,200
2026-03-31 $475,896 15,800
2026-03-31 $18,198,504 604,200
2026-03-31 $57,042,611 1,893,845
2025-12-31 $1,785,212 57,200
2025-12-31 $1,164,133 37,300
2025-09-30 $8,443,600 418,000
2025-09-30 $21,573,074 1,067,974
2025-09-30 $11,544,300 571,500
2025-06-30 $1,667,620 99,500
2025-06-30 $1,726,280 103,000
2025-06-30 $18,420,815 1,099,094
2025-03-31 $2,457,663 159,900
2025-03-31 $84,465,665 5,495,489
2025-03-31 $860,720 56,000
2024-12-31 $3,217,840 146,000
2024-12-31 $144,189,845 6,542,189
2024-12-31 $4,445,468 201,700
2024-09-30 $212,874,386 11,813,229
2024-09-30 $457,708 25,400
2024-09-30 $401,846 22,300
2024-06-30 $791,375 48,700
2024-06-30 $197,082,876 12,128,177
2024-06-30 $677,625 41,700
2024-03-31 $3,641,791 258,100
2024-03-31 $151,665,356 10,748,785
2024-03-31 $702,678 49,800
2023-12-31 $157,339,694 15,070,852
2023-12-31 $9,368,856 897,400
2023-12-31 $2,680,992 256,800
2023-09-30 $100,549,580 9,857,802
2023-09-30 $2,109,360 206,800
2023-09-30 $4,053,480 397,400
2023-06-30 $105,646,419 14,030,069
2023-06-30 $2,874,954 381,800
2023-06-30 $8,519,442 1,131,400
2023-03-31 $3,370,080 380,800
2023-03-31 $54,824,387 6,194,846
2023-03-31 $3,692,220 417,200
2022-12-31 $7,807,632 856,100
2022-12-31 $2,718,672 298,100
2022-12-31 $9,455,926 1,036,834
2022-09-30 $3,697,674 458,200
2022-09-30 $12,292,950 1,523,290
2022-09-30 $26,229,921 3,250,300
2022-06-30 $5,264,000 700,000
2022-06-30 $24,207,632 3,219,100
2022-06-30 $75,849,013 10,086,305